Cargando…
Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension
BACKGROUND: Elevated levels of an endogenous Na/K‐ATPase inhibitor marinobufagenin accompany salt‐sensitive hypertension and are implicated in cardiac fibrosis. Immunoneutralization of marinobufagenin reduces blood pressure in Dahl salt‐sensitive (Dahl‐S) rats. The effect of the anti‐marinobufagenin...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818028/ https://www.ncbi.nlm.nih.gov/pubmed/31576777 http://dx.doi.org/10.1161/JAHA.119.012138 |
_version_ | 1783463547561312256 |
---|---|
author | Zhang, Yongqing Wei, Wen Shilova, Victoria Petrashevskaya, Natalia N. Zernetkina, Valentina I. Grigorova, Yulia N. Marshall, Courtney A. Fenner, Rachel C. Lehrmann, Elin Wood, William H. Becker, Kevin G. Lakatta, Edward G. Bagrov, Alexei Y. Fedorova, Olga V. |
author_facet | Zhang, Yongqing Wei, Wen Shilova, Victoria Petrashevskaya, Natalia N. Zernetkina, Valentina I. Grigorova, Yulia N. Marshall, Courtney A. Fenner, Rachel C. Lehrmann, Elin Wood, William H. Becker, Kevin G. Lakatta, Edward G. Bagrov, Alexei Y. Fedorova, Olga V. |
author_sort | Zhang, Yongqing |
collection | PubMed |
description | BACKGROUND: Elevated levels of an endogenous Na/K‐ATPase inhibitor marinobufagenin accompany salt‐sensitive hypertension and are implicated in cardiac fibrosis. Immunoneutralization of marinobufagenin reduces blood pressure in Dahl salt‐sensitive (Dahl‐S) rats. The effect of the anti‐marinobufagenin monoclonal antibody on blood pressure, left ventricular (LV) and renal remodeling, and gene expression were investigated in hypertensive Dahl‐S rats. METHODS AND RESULTS: Dahl‐S rats were fed high NaCl (8%, HS; n=14) or low NaCl (0.1%, LS; n=14) diets for 8 weeks. Animals were administered control antibody (LS control antibody, LSC; HS control antibody, HSC; n=7 per group) or anti‐marinobufagenin antibody once on week 7 of diet intervention (n=7 per group). Levels of marinobufagenin, LV, and kidney mRNAs and proteins implicated in profibrotic signaling were assessed. Systolic blood pressure was elevated (211±8 versus 133±3 mm Hg, P<0.01), marinobufagenin increased 2‐fold in plasma (P<0.05) and 5‐fold in urine (P<0.01), LV and kidney weights increased, and levels of LV collagen‐1 rose 3.5‐fold in HSC versus LSC. Anti‐marinobufagenin antibody treatment decreased systolic blood pressure by 24 mm Hg (P<0.01) and reduced organ weights and level of LV collagen‐1 (P<0.01) in hypertensive Dahl salt‐sensitive rats with anti‐marinobufagenin antibody versus HSC. The expression of genes related to transforming growth factor‐β–dependent signaling was upregulated in the left ventricles and kidneys in HSC versus LSC groups and became downregulated following administration of anti‐marinobufagenin antibody to hypertensive Dahl‐S rats. Marinobufagenin also activated transforming growth factor‐β signaling in cultured ventricular myocytes from Dahl‐S rats. CONCLUSIONS: Immunoneutralization of heightened marinobufagenin levels in hypertensive Dahl‐S rats resulted in a downregulation of genes implicated in transforming growth factor‐β pathway, which indicates that marinobufagenin is an activator of profibrotic transforming growth factor‐β–dependent signaling in salt‐sensitive hypertension. |
format | Online Article Text |
id | pubmed-6818028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68180282019-11-04 Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension Zhang, Yongqing Wei, Wen Shilova, Victoria Petrashevskaya, Natalia N. Zernetkina, Valentina I. Grigorova, Yulia N. Marshall, Courtney A. Fenner, Rachel C. Lehrmann, Elin Wood, William H. Becker, Kevin G. Lakatta, Edward G. Bagrov, Alexei Y. Fedorova, Olga V. J Am Heart Assoc Original Research BACKGROUND: Elevated levels of an endogenous Na/K‐ATPase inhibitor marinobufagenin accompany salt‐sensitive hypertension and are implicated in cardiac fibrosis. Immunoneutralization of marinobufagenin reduces blood pressure in Dahl salt‐sensitive (Dahl‐S) rats. The effect of the anti‐marinobufagenin monoclonal antibody on blood pressure, left ventricular (LV) and renal remodeling, and gene expression were investigated in hypertensive Dahl‐S rats. METHODS AND RESULTS: Dahl‐S rats were fed high NaCl (8%, HS; n=14) or low NaCl (0.1%, LS; n=14) diets for 8 weeks. Animals were administered control antibody (LS control antibody, LSC; HS control antibody, HSC; n=7 per group) or anti‐marinobufagenin antibody once on week 7 of diet intervention (n=7 per group). Levels of marinobufagenin, LV, and kidney mRNAs and proteins implicated in profibrotic signaling were assessed. Systolic blood pressure was elevated (211±8 versus 133±3 mm Hg, P<0.01), marinobufagenin increased 2‐fold in plasma (P<0.05) and 5‐fold in urine (P<0.01), LV and kidney weights increased, and levels of LV collagen‐1 rose 3.5‐fold in HSC versus LSC. Anti‐marinobufagenin antibody treatment decreased systolic blood pressure by 24 mm Hg (P<0.01) and reduced organ weights and level of LV collagen‐1 (P<0.01) in hypertensive Dahl salt‐sensitive rats with anti‐marinobufagenin antibody versus HSC. The expression of genes related to transforming growth factor‐β–dependent signaling was upregulated in the left ventricles and kidneys in HSC versus LSC groups and became downregulated following administration of anti‐marinobufagenin antibody to hypertensive Dahl‐S rats. Marinobufagenin also activated transforming growth factor‐β signaling in cultured ventricular myocytes from Dahl‐S rats. CONCLUSIONS: Immunoneutralization of heightened marinobufagenin levels in hypertensive Dahl‐S rats resulted in a downregulation of genes implicated in transforming growth factor‐β pathway, which indicates that marinobufagenin is an activator of profibrotic transforming growth factor‐β–dependent signaling in salt‐sensitive hypertension. John Wiley and Sons Inc. 2019-10-02 /pmc/articles/PMC6818028/ /pubmed/31576777 http://dx.doi.org/10.1161/JAHA.119.012138 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Zhang, Yongqing Wei, Wen Shilova, Victoria Petrashevskaya, Natalia N. Zernetkina, Valentina I. Grigorova, Yulia N. Marshall, Courtney A. Fenner, Rachel C. Lehrmann, Elin Wood, William H. Becker, Kevin G. Lakatta, Edward G. Bagrov, Alexei Y. Fedorova, Olga V. Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension |
title | Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension |
title_full | Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension |
title_fullStr | Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension |
title_full_unstemmed | Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension |
title_short | Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension |
title_sort | monoclonal antibody to marinobufagenin downregulates tgfβ profibrotic signaling in left ventricle and kidney and reduces tissue remodeling in salt‐sensitive hypertension |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818028/ https://www.ncbi.nlm.nih.gov/pubmed/31576777 http://dx.doi.org/10.1161/JAHA.119.012138 |
work_keys_str_mv | AT zhangyongqing monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT weiwen monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT shilovavictoria monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT petrashevskayanatalian monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT zernetkinavalentinai monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT grigorovayulian monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT marshallcourtneya monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT fennerrachelc monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT lehrmannelin monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT woodwilliamh monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT beckerkeving monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT lakattaedwardg monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT bagrovalexeiy monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension AT fedorovaolgav monoclonalantibodytomarinobufagenindownregulatestgfbprofibroticsignalinginleftventricleandkidneyandreducestissueremodelinginsaltsensitivehypertension |